Biotech Values

[DewDiligence]

What do you think of companies who are normally quite active at investor conferences but who suddenly become much less active? Is this a bearish signal, for some reason a bullish signal, or, I presume, essentially no signal?

In general, I consider a diminishment in presenting activity neutral to mildly bearish. However, there’s a downside to a company’s presenting at too many investor conferences in a short period of time (people stop tuning in), so you have to avoid becoming unduly granular when assessing this signal.